// App-Quantinova.ai

PB1126 : Safety and efficacy of simoctocog alfa in patients with haemophilia A in routine clinical practice (GENA-99)

Researchers

Presenter

  • C. Berger

Principal Investigators

  • M. Sol Cruz

  • M. Mathias

  • E. Zanon

  • S. Siragusa

  • B. Pollio

  • H. Glosli

  • A. Batorova

  • E. Dmitriev

  • M. Janbain

  • J. Martinez

  • M. Penka

  • P. Radossi

  • S. Werner

  • G. Di Minno

Medical Centers

  • Hemophilia CRC Hospital, INSERM, U 1059, Jean Monnet University,, Saint-Etienne, Rhone-Alpes, France

  • Centro Diabetologico del Norte (CEDINOR), Salta, Salta, Argentina

  • PEDIAS INC, Guatemala City, Alta Verapaz, Guatemala

  • Teodoro Maldonado Carbo Specialty Hospital, Guayaquil, Guayas, Ecuador

  • Great Ormond Street Hospital for Children NHS Foundation Trust, London, United Kingdom

  • Medicina Generale, Azienda Ospedaliera di Padova, Padova, Veneto, Italy

  • AOUP Policlinico Giaccone, Palermo, Sicilia, Italy

  • Regina Margherita Children Hospital Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino, Piemonte, Italy

  • Oslo University Hospital, Oslo, Norway

  • National Haemophilia Center, Bratislava, Bratislava, Slovakia

  • Belarusian Research Center for Pediatric Oncology, Hematology and Immunology, Minsk, Belarus

  • Louisiana State University School of Medicine, New Orleans, Louisiana, United States

  • University of Cova da Beira, Centro Hospitalar Universitário Cova da Beira, EPE, Colviha, Castelo Branco, Portugal

  • Clinic of Children’s diseases, Faculty of Medicine, Vilnius University, Vilnius University Hospital Santaros Klinikos, Vilnius, Vilniaus Apskritis, Lithuania

  • Teaching Hospital of Faculty of Medicine of Masaryk University, Brno, Jihomoravsky kraj, Czech Republic

  • Istituto Oncologico Veneto, IRCCS, Castelfranco Veneto, Veneto, Italy

  • Octapharma USA, Paramus, New Jersey, United States

  • Azienda Ospedaliera Universitaria "Federico II", Naples, Italy

Locations

  • France

  • Argentina

  • Guatemala

  • Ecuador

  • United Kingdom

  • Italy

  • Norway

  • Slovakia

  • Belarus

  • United States

  • Portugal

  • Lithuania

  • Czech Republic

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

Disease

  • Hemophilia

Biomarkers

  • N/A

Drug/Treatment

  • simoctocog alfa

  • FVIII

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • NCT02962765

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved